Correlation Between Ideaya Biosciences and Stoke Therapeutics
Can any of the company-specific risk be diversified away by investing in both Ideaya Biosciences and Stoke Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ideaya Biosciences and Stoke Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ideaya Biosciences and Stoke Therapeutics, you can compare the effects of market volatilities on Ideaya Biosciences and Stoke Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ideaya Biosciences with a short position of Stoke Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ideaya Biosciences and Stoke Therapeutics.
Diversification Opportunities for Ideaya Biosciences and Stoke Therapeutics
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Ideaya and Stoke is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Ideaya Biosciences and Stoke Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stoke Therapeutics and Ideaya Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ideaya Biosciences are associated (or correlated) with Stoke Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stoke Therapeutics has no effect on the direction of Ideaya Biosciences i.e., Ideaya Biosciences and Stoke Therapeutics go up and down completely randomly.
Pair Corralation between Ideaya Biosciences and Stoke Therapeutics
Given the investment horizon of 90 days Ideaya Biosciences is expected to under-perform the Stoke Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Ideaya Biosciences is 1.73 times less risky than Stoke Therapeutics. The stock trades about -0.21 of its potential returns per unit of risk. The Stoke Therapeutics is currently generating about -0.11 of returns per unit of risk over similar time horizon. If you would invest 1,106 in Stoke Therapeutics on December 27, 2024 and sell it today you would lose (363.00) from holding Stoke Therapeutics or give up 32.82% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Ideaya Biosciences vs. Stoke Therapeutics
Performance |
Timeline |
Ideaya Biosciences |
Stoke Therapeutics |
Ideaya Biosciences and Stoke Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ideaya Biosciences and Stoke Therapeutics
The main advantage of trading using opposite Ideaya Biosciences and Stoke Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ideaya Biosciences position performs unexpectedly, Stoke Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stoke Therapeutics will offset losses from the drop in Stoke Therapeutics' long position.Ideaya Biosciences vs. AnaptysBio | Ideaya Biosciences vs. MeiraGTx Holdings PLC | Ideaya Biosciences vs. Keros Therapeutics | Ideaya Biosciences vs. Ventyx Biosciences |
Stoke Therapeutics vs. Adaptimmune Therapeutics Plc | Stoke Therapeutics vs. Black Diamond Therapeutics | Stoke Therapeutics vs. Relay Therapeutics | Stoke Therapeutics vs. Pliant Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |